Financial Consulate’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Financial Consulate's NVS Position: Q2 2026 in Review
Financial Consulate increased its Novartis (NVS) stake by 6.8% in Q2 2026, buying an estimated $4.95K and bringing the position to 515 shares worth $80.7K. The position accounts for 0.01% of the portfolio, ranked #267.
Financial Consulate first reported a position in NVS in Q3 2025 and has held it in 4 quarters since. 1,620 funds tracked by Wall St. Rank hold NVS as of Q2 2026.
- Financial Consulate held 515 shares of Novartis worth $80.7K as of Q2 2026.
- Financial Consulate bought 33 Novartis shares in Q2 2026, an estimated $4.95K.
- Novartis made up 0.01% of Financial Consulate's portfolio in Q2 2026, its #267 holding.
- Financial Consulate first reported a position in Novartis in Q3 2025 and has held it in 4 quarters since.
- 1,620 funds tracked by Wall St. Rank held Novartis as of Q2 2026.
Based on Financial Consulate's 13F filing for Q2 2026, filed 23 Jul 2026.